These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10386947)

  • 1. Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors.
    Tamiz AP; Whittemore ER; Woodward RM; Upasani RB; Keana JF
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1619-24. PubMed ID: 10386947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists.
    Tamiz AP; Cai SX; Zhou ZL; Yuen PW; Schelkun RM; Whittemore ER; Weber E; Woodward RM; Keana JF
    J Med Chem; 1999 Aug; 42(17):3412-20. PubMed ID: 10464027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.
    Tamiz AP; Whittemore ER; Zhou ZL; Huang JC; Drewe JA; Chen JC; Cai SX; Weber E; Woodward RM; Keana JF
    J Med Chem; 1998 Aug; 41(18):3499-506. PubMed ID: 9719603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent 1,3-disubstituted-9H-pyrido[3,4-b]indoles as new lead compounds in antifilarial chemotherapy.
    Srivastava SK; Agarwal A; Chauhan PM; Agarwal SK; Bhaduri AP; Singh SN; Fatima N; Chatterjee RK
    J Med Chem; 1999 May; 42(9):1667-72. PubMed ID: 10229635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-selective antagonism of NMDA receptors by nylidrin.
    Whittemore ER; Ilyin VI; Konkoy CS; Woodward RM
    Eur J Pharmacol; 1997 Oct; 337(2-3):197-208. PubMed ID: 9430414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4230-8. PubMed ID: 8277505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (+/-)-3-(4-hydroxyphenyl)pyrrolidines: selective antagonists at the 1A/2B NMDA receptor subtype.
    Guzikowski AP; Tamiz AP; Acosta-Burruel M; Hong-Bae S; Cai SX; Hawkinson JE; Keana JF; Kesten SR; Shipp CT; Tran M; Whittemore ER; Woodward RM; Wright JL; Zhou ZL
    J Med Chem; 2000 Mar; 43(5):984-94. PubMed ID: 10715162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Gere A; Agai-Csongor E; Agai B; Tárkányi G; Horváth C; Barta-Szalai G; Bozó E; Kiss C; Bielik A; Nagy J; Farkas S; Domány G
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3859-61. PubMed ID: 14552795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER; Ilyin VI; Woodward RM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-(3,4-dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor antagonists.
    Büttelmann B; Alanine A; Bourson A; Gill R; Heitz MP; Mutel V; Pinard E; Trube G; Wyler R
    Bioorg Med Chem Lett; 2003 May; 13(10):1759-62. PubMed ID: 12729659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxamides as novel NR2B selective NMDA receptor antagonists.
    Barta-Szalai G; Borza I; Bozó E; Kiss C; Agai B; Proszenyák A; Keseru GM; Gere A; Kolok S; Galgóczy K; Horváth C; Farkas S; Domány G
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3953-6. PubMed ID: 15225705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
    Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: a novel antagonist at the 1A/2B NMDA receptor subtype.
    Tamiz AP; Whittemore ER; Schelkun RM; Yuen PW; Woodward RM; Cai SX; Weber E; Keana JF
    Bioorg Med Chem Lett; 1998 Jan; 8(2):199-200. PubMed ID: 9871654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted indole-2-carboxylates as potent antagonists of the glycine binding site associated with the NMDA receptor.
    Micheli F; Di Fabio R; Baraldi D; Conti N; Cugola A; Gastaldi P; Giacobbe S; Marchioro C; Mugnaini M; Rossi L; Pecunioso A; Pentassuglia G
    Arch Pharm (Weinheim); 1999 Aug; 332(8):271-8. PubMed ID: 10489537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines.
    Wright JL; Gregory TF; Bigge CF; Boxer PA; Serpa K; Meltzer LT; Wise LD; Cai SX; Hawkinson JE; Konkoy CS; Whittemore ER; Woodward RM; Zhou ZL
    J Med Chem; 1999 Jul; 42(13):2469-77. PubMed ID: 10395488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 1-adrenoceptor reagents. Synthesis of some 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido and 5,6,11,11b-tetrahydro-1H-imidazo[1',5':1,2]pyrido[3,4-b]indole-1,3(2H) -diones.
    Lopez-Rodriguez ML; Morcillo MJ; Benhamu B; Fernandez E; Serrano J; Orensanz L
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):941-6. PubMed ID: 7641312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.